FWA
TRML

Freedom Wealth Alliance’s Tourmaline Bio TRML Stock Holding History

Freedom Wealth Alliance’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$45.4K Buy
+1,615
New +$47.3K 0.07% 44

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Freedom Wealth Alliance's TRML Position: Q3 2023 in Review

Freedom Wealth Alliance opened a new position in Tourmaline Bio (TRML) in Q3 2023: 1,615 shares worth $45.4K. The stake represents 0.07% of the portfolio and ranks #44 among its holdings.

48 funds tracked by Wall St. Rank hold TRML as of Q3 2023.

  • Freedom Wealth Alliance held 1,615 shares of Tourmaline Bio worth $45.4K as of Q3 2023.
  • Tourmaline Bio was a new Freedom Wealth Alliance position in Q3 2023.
  • Tourmaline Bio made up 0.07% of Freedom Wealth Alliance's portfolio in Q3 2023, its #44 holding.
  • 48 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2023.

Based on Freedom Wealth Alliance's 13F filing for Q3 2023, filed 30 Oct 2023.